Advertisement

Topics

$PGNX Reports Results of Phase 2/3 Trial of PSMA PET Imaging Agent PyL for the Detection of Prostate Cancer https://globenewswire.com/news-release/2018/10/05/1617353/0/en/Progenics-Reports-Results-of-Phase-2-3-Trial-of-PSMA-PET-Imaging-Agent-PyL-for-the-D

08:31 EDT 5 Oct 2018 | Odi Bruckman

Reports Results of Phase 2/3 Trial of PSMA PET Imaging Agent PyL for the Detection of Prostate Cancer https://globenewswire.com/news-release/2018/10/05/1617353/0/en/Progenics-Reports-Results-of-Phase-2-3-Trial-of-PSMA-PET-Imaging-Agent-PyL-for-the-Detection-of-Prostate-Cancer.html …

Original Article: $PGNX Reports Results of Phase 2/3 Trial of PSMA PET Imaging Agent PyL for the Detection of Prostate Cancer https://globenewswire.com/news-release/2018/10/05/1617353/0/en/Progenics-Reports-Results-of-Phase-2-3-Trial-of-PSMA-PET-Imaging-Agent-PyL-for-the-D

NEXT ARTICLE

More From BioPortfolio on "$PGNX Reports Results of Phase 2/3 Trial of PSMA PET Imaging Agent PyL for the Detection of Prostate Cancer https://globenewswire.com/news-release/2018/10/05/1617353/0/en/Progenics-Reports-Results-of-Phase-2-3-Trial-of-PSMA-PET-Imaging-Agent-PyL-for-the-D"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...